At Sartorius BIA Separations, we specialize in developing and manufacturing market-leading CIM® monolithic chromatographic columns, designed for the purification and analysis of large biomolecules. Our CIM columns are available in various formats for preparative, analytical, and screening purposes, making them essential in cell, gene, and other advanced therapies. They set the standard for manufacturing highly complex biomolecules, including AAV, Adeno, pDNA, mRNA, VLPs, viral vaccines, LNPs, exosomes, and bacteriophages.

Our Cornerstone® Biomanufacturing Development Services leverage over 27 years of hands-on experience with challenging biopharmaceutical products. We offer a comprehensive approach to integrated process development solutions, enhancing the robustness and yield of large biomolecule production while ensuring the safety of therapeutic products. Our technology is pivotal in manufacturing-scale purification, already used in the production of the first commercialized advanced therapeutics, and we maintain a strong presence with novel drug candidates in the clinical pipeline.

Additionally, our PATfix in-process biochromatography system with a multidetector setup aims to enhance bioprocess understanding, ensuring that quality is built into products by design. Complementing this, our Alkalizator system offers a fully automated in-line lysis solution, streamlining GMP-scale process development and protecting target DNA during processing. 

We are committed to advancing the fields of gene therapy and vaccines through innovative purification technologies and process development services.

MSS Events

Org chart

Teams

Offices